Company Directory / research
PrivateFor profitresearchGeneva, Switzerland
iOnctura
iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.
- Founded
- 2017 9 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $128M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
9 years old.
Reach
Website ranked #3,826,012 in the world for traffic, about 3k visits a month.
What it does
BiotechnologyHealth CareMedical DevicePharmaceutical
Funding, as listed
$128M currency not stated
- Rounds9
- LatestSeries b, Jun 2024
- Investors11, 7 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about iOnctura, field by field. Contact details are held but never shown.
The company
- Name
- iOnctura
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Founders
- Catherine Pickering
- Industry
- research
- Categories
- Biotechnology, Health Care, Medical Device, Pharmaceutical
Where
- City
- Geneva
- Country
- Switzerland
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #3,826,012
- Monthly web visits
- 3,085
Funding, as listed
- Total
- 127,704,419 (currency not stated)
- Rounds
- 9
- Latest round
- Series b
- Latest round date
- Jun 2024
- Investors
- 11
- Lead investors
- 7
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
iOnctura raised EUR80M in Series B financing.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Switzerland.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,795 companies in Switzerland and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.